Testing effectiveness (Phase 2)Study completedNCT01097096
What this trial is testing
Safety, Tolerability and Abeta-specific Antibody Response of Repeated i.m. Injections of Adjuvanted CAD106 in Mild Alzheimer Patients
Who this might be right for
Alzheimer's Disease
Novartis Pharmaceuticals 177